These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 24526609)

  • 1. N-homocysteinylation of apolipoprotein A-I impairs the protein's antioxidant ability but not its cholesterol efflux capacity.
    Miyazaki A; Sagae N; Usami Y; Sato M; Kameda T; Yoshimoto A; Ishimine N; Matsuda K; Sugano M; Hara M; Honda T; Tozuka M
    Biol Chem; 2014 Jun; 395(6):641-8. PubMed ID: 24526609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of reconstituted high density lipoprotein discs containing human apolipoprotein A-I (ApoA-I) variants with murine adipocytes and macrophages. Evidence for reduced cholesterol efflux promotion by apoA-I(Pro165-->Arg).
    von Eckardstein A; Castro G; Wybranska I; Theret N; Duchateau P; Duverger N; Fruchart JC; Ailhaud G; Assmann G
    J Biol Chem; 1993 Feb; 268(4):2616-22. PubMed ID: 8428938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Function of different proportions of apolipoprotein A-I cysteine mutants and apolipoprotein A-V on recombinant high-density lipoproteins
    Yan Y; Lu S; Jia S; Dong Q; Wang L; Wang Y
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 31023964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bovine apolipoprotein (apo)A-I displays more enhanced antioxidant and anti-atherosclerotic activity in lipid-free and lipid-bound states than human and porcine apoA-I.
    Kim SM; Park GY; Choi I; Cho KH
    Int J Mol Med; 2013 Oct; 32(4):843-50. PubMed ID: 23969702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ApoA-I mutants V156K and R173C promote anti-inflammatory function and antioxidant activities.
    Cho KH; Park SH; Han JM; Kim HC; Choi YK; Choi I
    Eur J Clin Invest; 2006 Dec; 36(12):875-82. PubMed ID: 17087782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cuban Sugar Cane Wax Alcohol Exhibited Enhanced Antioxidant, Anti-Glycation and Anti-Inflammatory Activity in Reconstituted High-Density Lipoprotein (rHDL) with Improved Structural and Functional Correlations: Comparison of Various Policosanols.
    Cho KH; Baek SH; Nam HS; Kim JE; Kang DJ; Na H; Zee S
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a sequence of apolipoprotein A-I associated with the efflux of intracellular cholesterol to human serum and apolipoprotein A-I containing particles.
    Sviridov D; Pyle L; Fidge N
    Biochemistry; 1996 Jan; 35(1):189-96. PubMed ID: 8555173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine modulates the effect of simvastatin on expression of ApoA-I and NF-kappaB/iNOS.
    Mikael LG; Rozen R
    Cardiovasc Res; 2008 Oct; 80(1):151-8. PubMed ID: 18540024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A point mutant of apolipoprotein A-I, V156K, exhibited potent anti-oxidant and anti-atherosclerotic activity in hypercholesterolemic C57BL/6 mice.
    Cho KH; Park SH; Han JM; Kim HC; Chung YJ; Choi I; Kim JR
    Exp Mol Med; 2007 Apr; 39(2):160-9. PubMed ID: 17464177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloperoxidase-derived oxidants modify apolipoprotein A-I and generate dysfunctional high-density lipoproteins: comparison of hypothiocyanous acid (HOSCN) with hypochlorous acid (HOCl).
    Hadfield KA; Pattison DI; Brown BE; Hou L; Rye KA; Davies MJ; Hawkins CL
    Biochem J; 2013 Jan; 449(2):531-42. PubMed ID: 23088652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of amino acids Glu146-->Arg160 in human apolipoprotein A-I (ApoA-ISeattle) alters lecithin:cholesterol acyltransferase activity and recruitment of cell phospholipid.
    Lindholm EM; Bielicki JK; Curtiss LK; Rubin EM; Forte TM
    Biochemistry; 1998 Apr; 37(14):4863-8. PubMed ID: 9538003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background.
    Sontag TJ; Krishack PA; Lukens JR; Bhanvadia CV; Getz GS; Reardon CA
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):262-9. PubMed ID: 24334873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of myeloperoxidase oxidation and
    Kameda T; Horiuchi Y; Shimano S; Yano K; Lai SJ; Ichimura N; Tohda S; Kurihara Y; Tozuka M; Ohkawa R
    Biol Chem; 2022 Feb; 403(3):265-277. PubMed ID: 34448387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced delivery of rapamycin by V156K-apoA-I high-density lipoprotein inhibits cellular proatherogenic effects and senescence and promotes tissue regeneration.
    Cho KH
    J Gerontol A Biol Sci Med Sci; 2011 Dec; 66(12):1274-85. PubMed ID: 21964553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of apolipoprotein A-I lipidation on the formation and function of pre-beta and alpha-migrating LpA-I particles.
    Sparks DL; Frank PG; Braschi S; Neville TA; Marcel YL
    Biochemistry; 1999 Feb; 38(6):1727-35. PubMed ID: 10026251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein A-I helix 6 negatively charged residues attenuate lecithin-cholesterol acyltransferase (LCAT) reactivity.
    Alexander ET; Bhat S; Thomas MJ; Weinberg RB; Cook VR; Bharadwaj MS; Sorci-Thomas M
    Biochemistry; 2005 Apr; 44(14):5409-19. PubMed ID: 15807534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipophorin III from Hyphantria cunea shows different anti-oxidant ability against LDL oxidation in the lipid-free and lipid-bound state.
    Seo SJ; Park KH; Cho KH
    Comp Biochem Physiol B Biochem Mol Biol; 2008 Dec; 151(4):433-9. PubMed ID: 18822383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol Efflux Capacity of Apolipoprotein A-I Varies with the Extent of Differentiation and Foam Cell Formation of THP-1 Cells.
    Yano K; Ohkawa R; Sato M; Yoshimoto A; Ichimura N; Kameda T; Kubota T; Tozuka M
    J Lipids; 2016; 2016():9891316. PubMed ID: 27957343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-function studies of apoA-I variants: site-directed mutagenesis and natural mutations.
    Sviridov D; Hoang A; Huang W; Sasaki J
    J Lipid Res; 2002 Aug; 43(8):1283-92. PubMed ID: 12177172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.